𝔖 Bobbio Scriptorium
✦   LIBER   ✦

Use of a combination of biomarkers in serum and urine to improve detection of prostate cancer

✍ Scribed by Celia Prior; Francisco Guillen-Grima; Jose E. Robles; David Rosell; Jose M. Fernandez-Montero; Xabier Agirre; Raúl Catena; Alfonso Calvo

Publisher
Springer-Verlag
Year
2010
Tongue
English
Weight
245 KB
Volume
28
Category
Article
ISSN
0724-4983

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Use of multiple biomarkers for a molecul
Use of multiple biomarkers for a molecular diagnosis of prostate cancer
✍ Kelly A. Landers; Michelle J. Burger; Michelle A. Tebay; David M. Purdie; Betty 📂 Article 📅 2005 🏛 John Wiley and Sons 🌐 French ⚖ 164 KB

## Abstract The identification of biomarkers capable of providing a reliable molecular diagnostic test for prostate cancer (PCa) is highly desirable clinically. We describe here 4 biomarkers, __UDP__‐__N__‐__Acetyl__‐α‐__D__‐__galactosamine transferase__ (__GalNAc__‐__T3__; not previously associate

Application of mass spectrometry to the
Application of mass spectrometry to the discovery of biomarkers for detection of prostate cancer
✍ O. John Semmes; Gunjan Malik; Mike Ward 📂 Article 📅 2006 🏛 John Wiley and Sons 🌐 English ⚖ 212 KB

## Abstract There has been an impressive emergence of mass spectrometry based technologies applied toward the study of proteins. Equally notable is the rapid adaptation of these technologies to biomedical approaches in the realm of clinical proteomics. Concerted efforts toward the elucidation of th

Serum chromogranin A: Early detection of
Serum chromogranin A: Early detection of hormonal resistance in prostate cancer patients
✍ James T. Wu; Mark E. Astill; Grace H. Liu; Robert A. Stephenson 📂 Article 📅 1998 🏛 John Wiley and Sons 🌐 English ⚖ 155 KB 👁 2 views

We monitored both chromogranin A (CgA) and neuron specific enolase (NSE) in serial serum specimens from 14 patients with prostate cancer (CAP patients) showing resistance to hormonal treatment. Elevated serum CgA was detected in 10 out of these 14 patients (71%) during treatment, and an early appear